MHRA awarded £1.3m for collaboration with the Bill and Melinda Gates Foundation and the World Health Organization
(WorldNews Africa)

New medicines and vaccines, for diseases such as malaria and HIV, may be introduced for the first time in LMIC`s where there are weak or no regulatory systems in place for effective safety monitoring. These new treatments have been developed with urgent public health needs in mind and therefore the need to gather and analyse information quickly on their safety and effectiveness is important. The healthcare and regulatory systems in these settings may often lack the tools, training...